160 results
Page 3 of 8
F-3
EX-23.1
x3w9l3
7 Jul 22
Shelf registration (foreign)
4:22pm
F-1
EX-23.1
zn09 2ntn2pk9
27 Feb 24
Registration statement (foreign)
4:15pm
20-F/A
EX-15.1
sp2g zqhkw4os
2 May 24
Annual report (foreign) (amended)
9:18am
F-1/A
EX-23.1
5fp8fk3
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-3
EX-23.1
v9okpgifnt
22 Aug 19
Shelf registration (foreign)
5:25pm
F-1
EX-23.1
aum7v o0xs
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.3
tz74z3r4bpgpz
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
F-1MEF
EX-23.1
yrd4gk
19 Nov 20
Registration statement to add securities to prior F-1 registration
9:33am
POS AM
EX-23.1
mfa 4azy5
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
POS AM
EX-23.1
7428uqvbrj4vntwyse6u
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
424B3
whwhe8xxxdnvqg3
10 Aug 23
Prospectus supplement
6:32am
6-K
EX-99.1
ncd1lvhy8fwhnjy3z21
11 Apr 24
Agreement and Plan of Merger
4:05pm
424B5
6medh0luu
14 Aug 23
Prospectus supplement for primary offering
9:14am
F-3
EX-5.1
0mrt0kq91k2gkukge1
20 Jun 18
Shelf registration (foreign)
2:38pm
6-K
pwen ldbgb2
3 Mar 20
Therapix Biosciences Ltd. Receives Nasdaq Notification Regarding Minimum Bid Requirements
9:00am
6-K
i4y8wr1iyc91
8 Jan 20
Report of Foreign Private Issuer
4:14pm
425
kezhiqjv0c0sep0 b2
12 Apr 24
Business combination disclosure
9:23am